Sulfasalazine (generic), Azulfidine News

This joint is relatively inflexible and connects the sacrum to the pelvis. It is associated with a variety of infectious or inflammatory conditions.

Dear Dr. Gott: Could you please address the causes and cures for Morton's neuroma of the foot? Is surgery the ultimate answer? If so, how effective and safe is it? Dear Reader: A Morton's neuroma is a noncancerous growth of thickened nerve tissue that can present in several areas of the body.

Q: I have been diagnosed with palindromic rheumatism. I had my first bout when I was 41 years old.

When it comes to the aches and pains of arthritis patients, folks have long believed dishing out more money meant better treatment.

In the first and largest researcher-initiated blinded study comparing the effectiveness of a drug treatment for rheumatoid arthritis, researchers found a $1,000 treatment and a $25,000 treatment to have the same effectiveness.

Phytomedics Inc. today announced the publication of the results of a 6 month, Phase 2b clinical trial with an extract of Tripterygium wilfordii Hook F to be developed as PMI-001, in patients with rheumatoid arthritis, in the August 18, 2009 issue of the Annals of Internal Medicine.

An ancient Chinese herbal remedy called "thunder god vine" helps reduce inflammation in people with rheumatoid arthritis, a new study shows.

Physicians often prescribe anti-inflammatory drugs such as sulfasalazine for the initial treatment of rheumatoid arthritis.

Background: Extracts of the medicinal plant Tripterygium wilfordii Hook F have been used in China for centuries to treat a spectrum of inflammatory diseases.

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Aug. 17, 2009 -- A Chinese herbal remedy may help ease symptoms in people with rheumatoid arthritis .

Patients with early rheumatoid arthritis who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor blockers, a Swedish study suggests.

Patients with early rheumatoid arthritis who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor blockers, a Swedish study suggests.

Patients with early rheumatoid arthritis who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor blockers, a Swedish study suggests.

In early rheumatoid arthritis patients who have failed methotrexate treatment, the addition of infliximab is more effective than conventional arthritis drugs, according to a study in the Aug.

Treating all patients with early rheumatoid arthritis with methotrexate monotherapy for a short period, followed by the addition of a tumour necrosis factor antagonist such as infliximab in patients with inadequate response to methotrexate, is the best treatment option and could prevent overtreatment, as well as reducing the side-effects and costs ...

Aug. 6, 2009 -- In a new study, rheumatoid arthritis researchers say they've found a good plan for treating rheumatoid arthritis in its early stages.A The study, published in The Lancet , included 487 adults in Sweden who had had rheumatoid arthritis for less than one year.

Patients with early rheumatoid arthritis who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor blockers, a Swedish study suggests.

Potential side effects of methotrexate can worry rheumatoid arthritis patients. But there may be good news -- long-term treatment with the drug appears safe, according to study results published in the July 2009 issue of the Annals of the Rheumatic Diseases .

Etanercept is a safe and effective adjunct to, or a replacement for, sulfasalazine in rheumatoid arthritis patients showing an inadequate response to treatment with sulfasalazine alone, researchers report in the July issue of Annals of the Rheumatic Diseases.